NICOLAS O. KROGH – CEO and member of the Board

Nicolas O. Krogh co-founded MipSalus and serves as Chief Executive Officer. Nicolas brings profound insight into business development, entrepreneurship, project management and IPR. Prior to co-founding MipSalus, Nicolas worked as an independent consultant focussing on patents and business development while specializing in pharmaceutical applications. His professional background also includes positions as Manager, Business Development at biotech company Pharmexa, Documentation Manager at patent agency Plougman & Vingtoft, Research Administrator/Internal Controller at Rigshospitalet in Copenhagen as well as Scientific Secretary in Rector’s Office at the University of Copenhagen.

Nicolas was born in 1964 and holds an MSc in Biochemistry from the University of Copenhagen.

KLAUS GREGORIUS – CSO and member of the Board

Klaus Gregorius co-founded MipSalus and serves as Chief Scientific Officer. Klaus brings strong innovation and scientific skills to MipSalus. Prior to co-founding MipSalus, Klaus was Manager, Biochemistry Development at Danish biotech company PreciSense where he headed a research department focussing on receptor-ligand interactions, supporting the company’s development of biosensors for blood glucose monitoring for diabetics. 1994-2003, Klaus was Research Scientist and Project Manager at the biotech company Pharmexa developing processes and analyses for therapeutic vaccine candidates (cancer and inflammatory diseases). Klaus has published 10 peer reviewed articles and is the named inventor of 17 patent applications. His background also includes a position as visiting Research Fellow at Linnaeus University, Kalmar.

Klaus was born in 1961 and holds an MSc in Biochemistry from the University of Copenhagen and a PhD in Chemistry from the Royal Danish Veterinary and Agricultural University (today: Faculty of Science under the University of Copenhagen).

JENS PETER TOFT – Chairman of the Board

Jens Peter Toft is an executive advisor and professional board member with positions in international companies, foundations, unit trusts as well as government-backed funds. Prior to setting up his financial and strategic advisory firm toft advice in 2008, Jens Peter Toft worked 25 years for one of Scandinavia’s leading financial institutions, Danske Bank, most recently as Executive Vice President and Global Head of Corporate Finance. In this position, he was deeply involved in structuring and executing a large number of Initial Public Offerings, M&A, privatizations, rights issues, restructurings and other transactions on behalf of clients from a variety of industries, including biotech and pharma.

Jens Peter was born in 1954 and holds a business degree from Aalborg University Centre.